Table 3 Validation of recently reported genes as associated with specific disorders

From: Clinical exome sequencing: results from 2819 samples reflecting 1000 families

Gene

Transcript

Inheritance, zygosity

cDNA change

AA change

Family segregation

Significance

Symptoms of patient (in HPO terms)

KCTD3

NM_016121.3

AR, homozygous

c.1036_1073del

p.(P346Tfs*4)

Inherited from parents

Likely Pathogenic

Hydrocephalus, delayed speech and language development, seizures, global developmental delay, Dandy–Walker malformation, polymicrogyria, abnormality of the cerebral white matter, abnormal cortical gyration

PPOX

NM_000309.3

AR, homozygous

c.1108_1119del

p.(G370_W373del)

Inherited from parents

Likely Pathogenic

Nystagmus, hypopigmentation of the skin, seizures, leukodystrophy, ichthyosis, primary adrenal insufficiency, abnormality of the heme biosynthetic pathway, neonatal asphyxia, inappropriate crying

SCN1B

NM_001037.4

AR, homozygous

c.449-2A>G

Inherited from parents

Likely pathogenic

Global developmental delay, hyperreflexia, generalized myoclonic seizures, muscular hypotonia of the trunk, feeding difficulties, epileptic encephalopathy

SCN3A

NM_006922.3

AD, heterozygous

c.3998C>T

p.(P1333L)

De novo

VUS

Seizures, generalized tonic-clonic seizures, febrile seizures, delayed myelination

PTPN23

NM_015466.2

AR, homozygous

c.904A>G

p.(M302V)

Inherited from parents

VUS

Microcephaly, delayed speech and language development, seizures, spasticity,global developmental delay, motor delay, developmental regression, brain atrophy, abnormality of movement

FRMPD4

NM_014728.3

AR, homozygous

c.380C>T

p.(P127L)

Inherited from parents

VUS

Intellectual disability